Thermo Fisher Scientific Inc (NYSE:TMO)
| 474.56 Delayed Data As of Dec 04 |  -2.64 / -0.55%Today’s Change | 250.21 Today|||52-Week Range 532.57 | +46.08% Year-to-Date |
Latest TMO News | Press Releases
Today’s Trading
| Previous close | 477.20 |
| Today’s open | 480.09 |
| Day’s range | 469.26 - 481.18 |
| Volume | 1,649,974 |
| Average volume (3 months) | 1,477,626 |
| Market cap | $179.7B |
Data as of 4:13pm ET, 12/04/2020
Growth & Valuation
| Earnings growth (last year) | +26.40% |
| Earnings growth (this year) | +47.29% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +4.86% |
| P/E ratio | 38.9 |
| Price/Sales | 5.13 |
| Price/Book | 6.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DHRDanaher Corp | +1.06 | +0.47% |
| AAgilent Technologies... | +1.51 | +1.33% |
| MTDMettler-Toledo Inter... | -0.12 | -0.01% |
| PKIPerkinElmer Inc | +3.78 | +2.74% |
Data as of 4:00pm ET, 12/04/2020
Financials
| Next reporting date | February 4, 2021 |
| EPS forecast (this quarter) | $6.10 |
| Annual revenue (last year) | $25.5B |
| Annual profit (last year) | $3.7B |
| Net profit margin | 14.47% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
